Theranostics and radiopharmacy innovator Bold Advanced Medical Future Health (BAMF) will invest $30 million and establish its headquarters in Grand Rapids, Michigan. The company expects to add over 200 life science jobs.
The company will lease at least 35,000 SF in the new Doug Meijer Medical Innovation Building, located within Michigan State University’s Grand Rapids Innovation Park at the Northeast corner of Monroe Avenue and Michigan Street at the West end of the famed Medical Mile corridor. Aside from the radiopharmacy and theranostics clinic, the location will serve as corporate headquarters for BAMF. The facility is expected to contain the world’s most advanced cyclotron-equipped radiopharmacy, molecular imaging clinic and theranostics clinic.
According to The Right Place, the first-of-its-kind dual-cyclotron radiopharmacy will produce novel radiopharmaceuticals on-site so cancer patients will receive confirmed diagnosis and treatment in a cutting-edge theranostics clinic during their same day visit. The facility will also supply both diagnostic and therapeutic radiopharmaceuticals to hospitals and independent clinics in the West Michigan area.
“The BAMF Health Precision Medicine Platform is considered the first and only platform of its kind in the world,” said BAMF Health founder and chief executive officer Dr. Anthony Chang. “We are eager and honored to bring BAMF Health’s lifesaving technology to patients in 2022. Our approach to achieve intelligence-based precision medicine will focus on effective therapies through precise and early diagnosis. It will guide patients to the most effective treatment, prevent unnecessary procedures and side effects, improve quality of life and outcomes, and reduce cost.”
The new BAMF headquarters is set to open in February 2022, corresponding to the opening of the 210,000 SF. Doug Meijer Medical Innovation Building. Throughout the planning and development of the Grand Rapids Innovation Park, the City of Grand Rapids has played an instrumental role in ensuring the park is a success.
“The MSU Grand Rapids Innovation Park is designed to create a health care innovation hub that will spur collaboration between academic research (biomedical, bioengineering and technology), health care providers, and health industries to commercialize, patent and license health innovation,” said Norman J. Beauchamp Jr., MD, MHS, MSU executive vice president for health sciences. “The radiopharmacy that BAMF Health is leasing from MSU in the Doug Meijer Medical Innovation Building embodies that vision and came about through collaboration between The Right Place, the city of Grand Rapids, private philanthropy and Michigan State University. Ultimately, this is finding new and better ways to bring health to all.”
The Right Place provided a wide variety of wrap-around business services to ensure BAMF’s successful landing in Grand Rapids. The organization first began partnering with BAMF in late 2016, making numerous connections and introductions for the fledgling startup. In 2017, The Right Place introduced the company (then called Rethink Imaging) to Michigan State University and Dr. Beauchamp. As that new relationship quickly grew, The Right Place team went on to provide connections with local capital resources for financial support and custom research services.
“This project was a ‘must-win’ for our team,” said Randy Thelen, president and CEO, The Right Place, Inc. “The technology and innovation that BAMF is bringing to the area of cancer detection and treatment, has the potential to save countless lives and significantly boost the global exposure of Medical Mile.”